Now that Procept BioRobotics Corp’s volume has hit 1.01 million, investors get a glimpse of its size.

On Tuesday, Procept BioRobotics Corp (NASDAQ: PRCT) opened lower -4.89% from the last session, before settling in for the closing price of $80.12. Price fluctuations for PRCT have ranged from $24.83 to $85.81 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

Annual sales at Healthcare sector company grew by 142.74% over the past five years. Company’s average yearly earnings per share was noted 15.84% at the time writing. With a float of $48.95 million, this company’s outstanding shares have now reached $50.77 million.

Let’s look at the performance matrix of the company that is accounted for 626 employees.

Procept BioRobotics Corp (PRCT) Insider Updates

A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Procept BioRobotics Corp is 5.74%, while institutional ownership is 84.67%. The most recent insider transaction that took place on Sep 16 ’24, was worth 2,062,679. In this transaction EVP, CFO of this company sold 25,000 shares at a rate of $82.51, taking the stock ownership to the 96,096 shares. Before that another transaction happened on Sep 16 ’24, when Company’s Affiliate proposed sale 50,000 for $81.11, making the entire transaction worth $4,055,500.

Procept BioRobotics Corp (PRCT) Performance Highlights and Predictions

If we go through the results of last quarter, which was made public on 6/30/2024, the company posted -0.51 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.51) by 0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.

According to the Wall Street analysts, stocks earnings will be around 15.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 23.10% during the next five years compared to -23.27% drop over the previous five years of trading.

Procept BioRobotics Corp (NASDAQ: PRCT) Trading Performance Indicators

Check out the current performance indicators for Procept BioRobotics Corp (PRCT). In the past quarter, the stock posted a quick ratio of 6.49. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 22.41.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.06, a number that is poised to hit -0.49 in the next quarter and is forecasted to reach -1.46 in one year’s time.

Technical Analysis of Procept BioRobotics Corp (PRCT)

Procept BioRobotics Corp (NASDAQ: PRCT) saw its 5-day average volume 0.57 million, a negative change from its year-to-date volume of 0.59 million. As of the previous 9 days, the stock’s Stochastic %D was 23.91%. Additionally, its Average True Range was 3.73.

During the past 100 days, Procept BioRobotics Corp’s (PRCT) raw stochastic average was set at 69.77%, which indicates a significant increase from 23.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 42.32% in the past 14 days, which was lower than the 57.13% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $72.52, while its 200-day Moving Average is $58.69. Nevertheless, the first resistance level for the watch stands at $79.40 in the near term. At $82.59, the stock is likely to face the second major resistance level. The third major resistance level sits at $85.60. If the price goes on to break the first support level at $73.19, it is likely to go to the next support level at $70.18. Assuming the price breaks the second support level, the third support level stands at $66.99.

Procept BioRobotics Corp (NASDAQ: PRCT) Key Stats

There are currently 51,424K shares outstanding in the company with a market cap of 3.96 billion. Presently, the company’s annual sales total 136,190 K according to its annual income of -105,900 K. Last quarter, the company’s sales amounted to 53,350 K and its income totaled -25,630 K.